What is CNTX's dilution risk score?

CNTX has a latest available DilutionScore record of 41/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CNTX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CNTX?

DilutionWatch tracks 25 SEC filing types for CNTX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CNTX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CNTX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CNTX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CNTX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CNTX Dilution Risk Score: 41/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

25

📊 Float Risk

45

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 7%

🔄 Reverse Split model est. 15%

• 52-week low $0.52 has breached $1

🔔 Track CNTX — Get forecast alerts →

Market Data

Market Cap$261.86M

Shares Outstanding91.88M

Float42.82M

Cash$42.99M

Debt$282.4K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 13.6% shares (2026Q1 vs prior)

61 institutional holders · 82.93M shares

#1 MPM BIOIMPACT LLC 10.68M shares

#2 Avidity Partners Management LP 10.00M shares

#3 Nextech Invest, Ltd. 7.42M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.83M

Days to Cover4.2

% of Float13.6%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2022-12-31

4 INSIDER TRANSACTION 2026-06-26

Full SEC filing analysis available with free account →

Recent News

Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c GlobeNewswire · Jul 10

CNTX Hits Worst Day In History After Ovarian Cancer Trial Data — But Analysts Se Stocktwits · Jun 15

Small Biotech Context Therapeutics Reports 29% Response Rate In Ovarian Cancer S Benzinga · Jun 15

Factual CNTX Dilution Snapshot

Context Therapeutics Inc. (CNTX) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for CNTX: 4 on 2026-06-26; 4 on 2026-06-26; 4 on 2026-06-26.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.